Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

The antifungal efficacy, pharmacokinetics, and safety of caspofungin (CAS) were investigated in the treatment and prophylaxis of invasive pulmonary aspergillosis due to Aspergillus fumigatus in persistently neutropenic rabbits. Antifungal therapy consisted of 1, 3, or 6 mg of CAS/kg of body weight/d...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Petraitiene, Ruta, Petraitis, Vidmantas, Groll, Andreas H., Sein, Tin, Schaufele, Robert L., Francesconi, Andrea, Bacher, John, Avila, Nilo A., Walsh, Thomas J.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2002
Matèries:	Experimental Therapeutics
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127008/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11751105/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.1.12-23.2002
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!